Enhanced autophagy in cytarabine arabinoside-resistant U937 leukemia cells and its potential as a target for overcoming resistance

Cheong,June‑Won; Kim,Yundeok; Eom,Ju In; Jeung,Hoi‑Kyung; Min,Yoo Hong

doi:10.3892/mmr.2016.4949

Enhanced autophagy in cytarabine arabinoside-resistant U937 leukemia cells and its potential as a target for overcoming resistance

Authors:
- June‑Won Cheong
- Yundeok Kim
- Ju In Eom
- Hoi‑Kyung Jeung
- Yoo Hong Min
View Affiliations

Affiliations: Department of Internal Medicine, Yonsei University College of Medicine, Seoul 120‑752, Republic of Korea, Medical Research Center, Yonsei University College of Medicine, Seoul 120‑752, Republic of Korea
Published online on: February 29, 2016 https://doi.org/10.3892/mmr.2016.4949
Pages: 3433-3440
Copyright: © Cheong et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Autophagy is a lysosomal degradation mechanism that is essential for cell survival, differentiation, development, and homeostasis. Autophagy protects cells from various stresses, including protecting normal cells from harmful metabolic conditions, and cancer cells from chemotherapeutics. In the current study, a cytarabine arabinoside (Ara‑C)‑sensitive U937 leukemia cell line and an Ara‑C‑resistant U937 (U937/AR) cell line were assessed for baseline autophagy activity by investigating the LC3‑I conversion to LC3‑II, performing EGFP‑LC3 puncta, an acidic autophagolysosome assay, and measuring the expression of various autophagy‑related genes. The results demonstrated significantly higher autophagic activity in the U937/AR cells compared with the U937 cells, when the cells were cultured with or without serum. Furthermore, an increase in the autophagic activity in starved U937/AR cells was demonstrated, compared with that in the starved U937 cells. Administration of an autophagy inhibitor demonstrated no change in cell death in the two cell lines when cultured with serum, however, it induced cell death regardless of the Ara‑C sensitivity when the cell lines were cultured without serum. In addition, the U937 cells demonstrated an Ara‑C resistance when cultured without serum. Co‑treatment with Ara‑C and the autophagy inhibitor significantly induced cell death in the U937/AR and Ara‑C‑sensitive U937 cells. In conclusion, autophagy serves an important role in protecting U937 cells from Ara‑C and in the development of Ara‑C resistance. Inhibition of autophagy combined with the Ara‑C treatment in the U937 cells augmented the anti‑leukemic effect of Ara‑C and overcame Ara‑C resistance, suggesting that autophagy may be an important therapeutic target to further improve the treatment outcome in patients with acute myeloid leukemia.

View Figures

View References

1	Levine B and Kroemer G: Autophagy in the pathogenesis of disease. Cell. 132:27–42. 2008. View Article : Google Scholar : PubMed/NCBI
2	Yang Z and Klionsky DJ: Mammalian autophagy: Core molecular machinery and signaling regulation. Curr Opin Cell Biol. 22:124–131. 2010. View Article : Google Scholar :
3	Murrow L and Debnath J: Autophagy as a stress-response and quality-control mechanism: Implications for cell injury and human disease. Annu Rev Pathol. 8:105–137. 2013. View Article : Google Scholar
4	Cully M, You H, Levine AJ and Mak TW: Beyond PTEN mutations: The PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat Rev Cancer. 6:184–192. 2006. View Article : Google Scholar : PubMed/NCBI
5	Schwartz RA, Fernández G, Kotulska K and Jóźwiak S: Tuberous sclerosis complex: Advances in diagnosis, genetics, and management. J Am Acad Dermatol. 57:189–202. 2007. View Article : Google Scholar : PubMed/NCBI
6	Ligresti G, Militello L, Steelman LS, Cavallaro A, Basile F, Nicoletti F, Stivala F, McCubrey JA and Libra M: PIK3CA mutations in human solid tumors: Role in sensitivity to various therapeutic approaches. Cell Cycle. 8:1352–1358. 2009. View Article : Google Scholar : PubMed/NCBI
7	Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H and Levine B: Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature. 402:672–676. 1999. View Article : Google Scholar : PubMed/NCBI
8	Notte A, Leclere L and Michiels C: Autophagy as a mediator of chemotherapy-induced cell death in cancer. Biochem Pharmacol. 82:427–434. 2011. View Article : Google Scholar : PubMed/NCBI
9	Liu L, Yang M, Kang R, Wang Z, Zhao Y, Yu Y, Xie M, Yin X, Livesey KM, Lotze MT, et al: HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells. Leukemia. 25:23–31. 2011. View Article : Google Scholar
10	Pan Y, Gao Y, Chen L, Gao G, Dong H, Yang Y, Dong B and Chen X: Targeting autophagy augments in vitro and in vivo antimyeloma activity of DNA-damaging chemotherapy. Clin Cancer Res. 17:3248–3258. 2011. View Article : Google Scholar : PubMed/NCBI
11	Carew JS, Nawrocki ST, Kahue CN, Zhang H, Yang C, Chung L, Houghton JA, Huang P, Giles FJ and Cleveland JL: Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance. Blood. 110:313–322. 2007. View Article : Google Scholar : PubMed/NCBI
12	Yang L, Yang M, Zhang H, Wang Z, Yu Y, Xie M, Zhao M, Liu L and Cao L: S100A8-targeting siRNA enhances arsenic trioxide-induced myeloid leukemia cell death by down-regulating autophagy. Int J Mol Med. 29:65–72. 2012.
13	Zhu S, Cao L, Yu Y, Yang L, Yang M, Liu K, Huang J, Kang R, Livesey KM and Tang D: Inhibiting autophagy potentiates the anticancer activity of IFN1α/IFNα in chronic myeloid leukemia cells. Autophagy. 9:317–327. 2013. View Article : Google Scholar :
14	Amrein L, Soulières D, Johnston JB and Aloyz R: p53 and autophagy contribute to dasatinib resistance in primary CLL lymphocytes. Leuk Res. 35:99–102. 2011. View Article : Google Scholar
15	Larson RA: New agents for induction and postremission therapy of acute myeloid leukemia. Leukemia. 15:675–676. 2001. View Article : Google Scholar : PubMed/NCBI
16	Mathew R, Karantza-Wadsworth V and White E: Role of autophagy in cancer. Nat Rev Cancer. 7:961–967. 2007. View Article : Google Scholar : PubMed/NCBI
17	Ryan KM: p53 and autophagy in cancer: Guardian of the genome meets guardian of the proteome. Eur J Cancer. 47:44–50. 2011. View Article : Google Scholar
18	García-Arencibia M, Hochfeld WE, Toh PP and Rubinsztein DC: Autophagy, a guardian against neurodegeneration. Semin Cell Dev Biol. 21:691–698. 2010. View Article : Google Scholar : PubMed/NCBI
19	Scheper W, Nijholt DA and Hoozemans JJ: The unfolded protein response and proteostasis in Alzheimer disease: Preferential activation of autophagy by endoplasmic reticulum stress. Autophagy. 7:910–911. 2011. View Article : Google Scholar : PubMed/NCBI
20	Martinez-Vicente M and Cuervo AM: Autophagy and neurodegeneration: When the cleaning crew goes on strike. Lancet Neurol. 6:352–361. 2007. View Article : Google Scholar : PubMed/NCBI
21	Puls I, Oh SJ, Sumner CJ, Wallace KE, Floeter MK, Mann EA, Kennedy WR, Wendelschafer-Crabb G, Vortmeyer A, Powers R, et al: Distal spinal and bulbar muscular atrophy caused by dynactin mutation. Ann Neurol. 57:687–694. 2005. View Article : Google Scholar : PubMed/NCBI
22	Czaja MJ, Ding WX, Donohue TM Jr, Friedman SL, Kim JS, Komatsu M, Lemasters JJ, Lemoine A, Lin JD, Ou JH, et al: Functions of autophagy in normal and diseased liver. Autophagy. 9:1131–1158. 2013. View Article : Google Scholar : PubMed/NCBI
23	Katsetos CD, Koutzaki S and Melvin JJ: Mitochondrial dysfunction in neuromuscular disorders. Semin Pediatr Neurol. 20:202–215. 2013. View Article : Google Scholar : PubMed/NCBI
24	Sugimoto S: A novel vacuolar myopathy with dilated cardiomyopathy. Autophagy. 3:638–639. 2007. View Article : Google Scholar : PubMed/NCBI
25	Edinger AL and Thompson CB: Defective autophagy leads to cancer. Cancer Cell. 4:422–424. 2003. View Article : Google Scholar
26	Karantza-Wadsworth V and White E: Role of autophagy in breast cancer. Autophagy. 3:610–613. 2007. View Article : Google Scholar : PubMed/NCBI
27	Sheen JH, Zoncu R, Kim D and Sabatini DM: Defective regulation of autophagy upon leucine deprivation reveals a targetable liability of human melanoma cells in vitro and in vivo. Cancer Cell. 19:613–628. 2011. View Article : Google Scholar : PubMed/NCBI
28	Rouschop KM, van den Beucken T, Dubois L, Niessen H, Bussink J, Savelkouls K, Keulers T, Mujcic H, Landuyt W, Voncken JW, et al: The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5. J Clin Invest. 120:127–141. 2010. View Article : Google Scholar :
29	Karpathiou G, Sivridis E, Koukourakis M, Mikroulis D, Bouros D, Froudarakis M and Giatromanolaki A: Light-chain 3A autophagic activity and prognostic significance in non-small cell lung carcinomas. Chest. 140:127–134. 2010. View Article : Google Scholar : PubMed/NCBI
30	Savaraj N, You M, Wu C, Wangpaichitr M, Kuo MT and Feun LG: Arginine deprivation, autophagy, apoptosis (AAA) for the treatment of melanoma. Curr Mol Med. 10:405–412. 2010. View Article : Google Scholar : PubMed/NCBI
31	Koukourakis MI, Giatromanolaki A, Sivridis E, Pitiakoudis M, Gatter KC and Harris AL: Beclin 1 over- and underexpression in colorectal cancer: Distinct patterns relate to prognosis and tumour hypoxia. Br J Cancer. 103:1209–1214. 2010. View Article : Google Scholar : PubMed/NCBI
32	Turcotte S, Chan DA, Sutphin PD, Hay MP, Denny WA and Giaccia AJ: A molecule targeting VHL-deficient renal cell carcinoma that induces autophagy. Cancer Cell. 14:90–102. 2008. View Article : Google Scholar : PubMed/NCBI
33	Kim RH, Bold RJ and Kung HJ: ADI, autophagy and apoptosis: Metabolic stress as a therapeutic option for prostate cancer. Autophagy. 5:567–568. 2009. View Article : Google Scholar : PubMed/NCBI
34	Boone BA, Bahary N, Zureikat AH, Moser AJ, Normolle DP, Wu WC, Singhi AD, Bao P, Bartlett DL, Liotta LA, et al: Safety and biologic response of pre-operative autophagy inhibition in combination with gemcitabine in patients with pancreatic adenocarcinoma. Ann Surg Oncol. 22:4402–4410. 2015. View Article : Google Scholar : PubMed/NCBI
35	Levy JM and Thorburn A: Targeting autophagy during cancer therapy to improve clinical outcomes. Pharmacol Ther. 131:130–141. 2011. View Article : Google Scholar : PubMed/NCBI
36	Fanzani A, Zanola A, Rovetta F, Rossi S and Aleo MF: Cisplatin triggers atrophy of skeletal C2C12 myotubes via impairment of Akt signalling pathway and subsequent increment activity of proteasome and autophagy systems. Toxicol Appl Pharmacol. 250:312–321. 2011. View Article : Google Scholar
37	Zhao D, Yuan H, Yi F, Meng C and Zhu Q: Autophagy prevents doxorubicin-induced apoptosis in osteosarcoma. Mol Med Rep. 9:1975–1981. 2014.PubMed/NCBI
38	Ekiz HA, Can G and Baran Y: Role of autophagy in the progression and suppression of leukemias. Crit Rev Oncol Hematol. 81:275–285. 2012. View Article : Google Scholar
39	Helgason GV, Karvela M and Holyoake TL: Kill one bird with two stones: Potential efficacy of BCR-ABL and autophagy inhibition in CML. Blood. 118:2035–2043. 2011. View Article : Google Scholar : PubMed/NCBI
40	Orfali N, McKenna SL, Cahill MR, Gudas LJ and Mongan NP: Retinoid receptor signaling and autophagy in acute promyelocytic leukemia. Exp Cell Res. 324:1–12. 2014. View Article : Google Scholar : PubMed/NCBI
41	Watson AS, Mortensen M and Simon AK: Autophagy in the pathogenesis of myelodysplastic syndrome and acute myeloid leukemia. Cell Cycle. 10:1719–1725. 2011. View Article : Google Scholar : PubMed/NCBI
42	O'Donovan TR, O'Sullivan GC and McKenna SL: Induction of autophagy by drug-resistant esophageal cancer cells promotes their survival and recovery following treatment with chemotherapeutics. Autophagy. 7:509–524. 2011. View Article : Google Scholar : PubMed/NCBI
43	Zeng X, Yan T, Schupp JE, Seo Y and Kinsella TJ: DNA mismatch repair initiates 6-thioguanine-induced autophagy through p53 activation in human tumor cells. Clin Cancer Res. 13:1315–1321. 2007. View Article : Google Scholar : PubMed/NCBI
44	Yang C, Tong Y, Ni W, Liu J, Xu W, Li L, Liu X, Meng H and Qian W: Inhibition of autophagy induced by overexpression of mda-7/interleukin-24 strongly augments the antileukemia activity in vitro and in vivo. Cancer Gene Ther. 17:109–119. 2010. View Article : Google Scholar
45	Zhao X, Liu J, Peng M, Liu J and Chen F: BMP4 is involved in the chemoresistance of myeloid leukemia cells through regulating autophagy-apoptosis balance. Cancer Invest. 31:555–562. 2013. View Article : Google Scholar : PubMed/NCBI
46	Yang M, Zeng P, Kang R, Yu Y, Yang L, Tang D and Cao L: S100A8 contributes to drug resistance by promoting autophagy in leukemia cells. PLoS One. 9:e972422014. View Article : Google Scholar : PubMed/NCBI